We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$80.7M
AUM Growth
-$5.14M
Cap. Flow
-$10.7M
Cap. Flow %
-13.28%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
IPSC icon
Century Therapeutics
IPSC
+$416K

Top Sells

Rank Stock Value
1
AUTL
Autolus Therapeutics
AUTL
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$386M
$67.4M 83.42%
18,554,624
-2,792,205
-13% -$11.1M
ACHL
2
DELISTED
Achilles Therapeutics
ACHL
$11.3M 14.01%
11,086,909
– –
IPSC icon
3
Century Therapeutics
IPSC
$381M
$2.07M 2.57%
1,213,056
+212,285
+21% +$416K

Similar funds

BAM
BTS Asset Management Lincoln, Massachusetts $25.9M AUM 2.16% 1-Year Est. Return
FCC
Florin Court Capital London, United Kingdom $26.5M AUM 34.2% 1-Year Est. Return
BWG
Berry Wealth Group Granbury, Texas $26.8M AUM 31.56% 1-Year Est. Return
LTM
Lotus Technology Management Orlando, Florida $27M AUM
TCM
Teza Capital Management Chicago, Illinois $27.3M AUM 29.09% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
BCM
Bancreek Capital Management Santa Monica, California $23.1M AUM 4.01% 1-Year Est. Return
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 33.03% 1-Year Est. Return

Syncona Portfolio's Q3 2024 Portfolio in Review

As of Q3 2024, Syncona Portfolio held 3 positions worth $80.7M, down 6% from $85.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syncona Portfolio withdrew a net $10.7M in Q3 2024, reducing 1 holding. Its largest reduction was Autolus Therapeutics, cutting an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Syncona Portfolio added an estimated $416K to Century Therapeutics.

  • Syncona Portfolio added most to Century Therapeutics in Q3 2024, an estimated $416K increase.
  • Syncona Portfolio's biggest Q3 2024 reduction was Autolus Therapeutics, cutting an estimated $11.1M.
  • Syncona Portfolio's ten largest holdings make up 100% of its $80.7M portfolio in Q3 2024.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q3 2024.
  • Syncona Portfolio's portfolio value fell 6% quarter-over-quarter to $80.7M.

Based on Syncona Portfolio's 13F filing for Q3 2024, filed 14 Nov 2024.